These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38008816)

  • 1. A review on in silico prediction of the environmental risks posed by pharmaceutical emerging contaminants.
    Gao J; Zhao J; Chen X; Wang J
    Environ Monit Assess; 2023 Nov; 195(12):1535. PubMed ID: 38008816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER.
    Schowanek D; Webb S
    Toxicol Lett; 2002 May; 131(1-2):39-50. PubMed ID: 11988357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.
    Kar S; Roy K; Leszczynski J
    Methods Mol Biol; 2018; 1800():395-443. PubMed ID: 29934904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical environmental risk assessment of ten used pharmaceuticals in Belo Horizonte, Brazil.
    Neves AC; Mol MPG
    Environ Monit Assess; 2019 Apr; 191(5):275. PubMed ID: 30976940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the potential risks posed by antidepressants as emerging contaminants in fish based on network pharmacological analysis.
    Zhao J; Gao J; Ma S; Chen X; Wang J
    Toxicol In Vitro; 2024 Aug; 99():105872. PubMed ID: 38851602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting variability of aquatic concentrations of human pharmaceuticals.
    Kostich MS; Batt AL; Glassmeyer ST; Lazorchak JM
    Sci Total Environ; 2010 Sep; 408(20):4504-10. PubMed ID: 20619877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals.
    Sangion A; Gramatica P
    Environ Res; 2016 May; 147():297-306. PubMed ID: 26921826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
    Mansour F; Al-Hindi M; Saad W; Salam D
    Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
    Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
    J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of different parameters for estimating pharmaceutical exposure seeking an improved environmental risk assessment.
    Pereira AMPT; Silva LJG; Lino CM; Meisel LM; Pena A
    Sci Total Environ; 2017 Dec; 603-604():226-236. PubMed ID: 28628814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G; Persoon C; Currie R
    Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Eco)toxicological maps: A new risk assessment method integrating traditional and in silico tools and its application in the Ledra River (Italy).
    Raitano G; Goi D; Pieri V; Passoni A; Mattiussi M; Lutman A; Romeo I; Manganaro A; Marzo M; Porta N; Baderna D; Colombo A; Aneggi E; Natolino F; Lodi M; Bagnati R; Benfenati E
    Environ Int; 2018 Oct; 119():275-286. PubMed ID: 29982131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.
    Letsinger S; Kay P
    Environ Sci Pollut Res Int; 2019 Feb; 26(4):3479-3491. PubMed ID: 30515684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO
    Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO
    Toxicol Lett; 2002 May; 131(1-2):137-43. PubMed ID: 11988366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystems.
    Arnold KE; Boxall AB; Brown AR; Cuthbert RJ; Gaw S; Hutchinson TH; Jobling S; Madden JC; Metcalfe CD; Naidoo V; Shore RF; Smits JE; Taggart MA; Thompson HM
    Biol Lett; 2013 Aug; 9(4):20130492. PubMed ID: 23804293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.